Our findings demonstrated that distinct GSCs and GBM tumors exhibited differential IFN signaling, which is tightly correlated with mesenchymal phenotypes, and that basal IFN/STAT1 was a critical factor in IFN-β-mediated GSC cell death. The gene discussed is IFNB1; the disease is glioblastoma.